Unim Brigid, De Vito Corrado, Hagan Julie, Villari Paolo, Knoppers Bartha Maria, Zawati Ma'n
Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Centre of Genomics and Policy, McGill University, Montreal, QC, Canada.
Front Genet. 2020 Mar 4;11:127. doi: 10.3389/fgene.2020.00127. eCollection 2020.
Research in the field of genomics and genetics has evolved in recent years and so has the demand of consumers who are increasingly interested in genomic prediction of diseases and various traits. The aim of this study is to identify genetic service delivery models, policies governing the use of genomics medicine, and measures to evaluate genetic services in the province of Quebec, Canada.
An questionnaire was designed and administered online in 2017 to healthcare workers with good knowledge or experience in the provision of BReast CAncer genes 1 and 2 (BRCA1/2), Lynch syndrome, familial hypercholesterolemia, inherited thrombophilia genetic tests, engaged in policy planning or evaluation of genetic services. A quali-quantitative analysis of the survey results was performed.
Thirty professionals participated in the study. The delivery models are classified in five categories according to the leading role of healthcare professionals in patient care pathways: i) the geneticist model; ii) the primary care model; iii) the medical specialist model; iv) the population screening program model; and v) the direct-to-consumer model. Barriers to genetic services are the coverage of genetic tests by the publicly funded healthcare system, the availability of qualified personnel, and the number of genetic centers. Regulatory oversight concerning the provision of genetic services appears to be insufficient.
Integration between genetics and the overall healthcare system in Quebec is in an early phase. Current models of genetic services require good level of genetic knowledge by all medical specialists, collaboration among different healthcare personnel, and work redistribution. The proper implementation of genomics into healthcare can be achieved through education and training, proper regulatory oversight, genomic policies, and public awareness.
近年来,基因组学和遗传学领域的研究不断发展,消费者对疾病和各种性状的基因组预测的兴趣也与日俱增。本研究的目的是确定加拿大魁北克省的遗传服务提供模式、基因组医学使用的管理政策以及评估遗传服务的措施。
2017年设计并在线发放了一份问卷,调查对象为在提供乳腺癌1号和2号基因(BRCA1/2)、林奇综合征、家族性高胆固醇血症、遗传性血栓形成基因检测方面有丰富知识或经验,且参与遗传服务政策规划或评估的医护人员。对调查结果进行了定性和定量分析。
30名专业人员参与了该研究。根据医护人员在患者护理路径中的主导作用,服务提供模式分为五类:i)遗传学家模式;ii)初级保健模式;iii)医学专家模式;iv)人群筛查项目模式;v)直接面向消费者模式。遗传服务的障碍包括公共资助医疗系统对基因检测的覆盖范围、合格人员的可获得性以及基因中心的数量。遗传服务提供方面的监管监督似乎不足。
魁北克省遗传学与整体医疗系统的整合尚处于早期阶段。当前的遗传服务模式要求所有医学专家具备良好的遗传学知识水平,不同医护人员之间进行协作,并重新分配工作。通过教育与培训、适当的监管监督、基因组政策以及公众意识,可以实现基因组学在医疗保健中的正确应用。